Showing 1,581 - 1,600 results of 2,274 for search '"type 2 diabetes"', query time: 0.12s Refine Results
  1. 1581

    Peran Antioksidan pada Non Alcoholic Fatty Liver Disease (NAFLD) by Yusri Diane Jurnalis, Yorva Sayoeti, Elfitrimelly .

    Published 2014-01-01
    “…NAFLD related with obesity, type 2 diabetes mellitus and metabolic syndrome. Insulin resistance and oxidative stress have important role in molecular pathogenesis of NAFLD. …”
    Get full text
    Article
  2. 1582

    Bile acids and incretins as modulators of obesity-associated atherosclerosis by Andrijana Kirsch, Juergen Gindlhuber, Diana Zabini, Elena Osto, Elena Osto

    Published 2025-01-01
    “…Obesity is one of the major global health concerns of the 21st century, associated with many comorbidities such as type 2 diabetes mellitus (T2DM), metabolic dysfunction-associated steatotic liver disease, and early and aggressive atherosclerotic cardiovascular disease, which is the leading cause of death worldwide. …”
    Get full text
    Article
  3. 1583

    Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers by Li Lai, Yohannes T. Ghebremariam

    Published 2016-01-01
    “…Insulin resistance syndrome (IRS) is a configuration of cardiovascular risk factors involved in the development of metabolic disorders including type 2 diabetes mellitus. In addition to diet, age, socioeconomic, and environmental factors, genetic factors that impair insulin signaling are centrally involved in the development and exacerbation of IRS. …”
    Get full text
    Article
  4. 1584

    Recommendations for dispensing magnesium products in pharmacy practice and primary health care by Piotr Merks, Urszula Religioni, Marta Jakubowska, Sainul Abideen Parakkal, Suhaj Abdulsalim, Agnieszka Neumann-Podczaska, Beata Chełstowska, Mazhuvanchery Kesavan Unnikrishnan, Alicja Szatko, Piotr Glinicki, Shabeer Ali Thorakkattil, Zbigniew Doniec, Regis Vaillancourt, Dagmara Hering

    Published 2024-12-01
    “…In this context, guidelines were developed to help identify magnesium deficiency in patients with type 2 diabetes, insulin resistance, migraines, fibromyalgia, depression, anxiety states or hypertension. …”
    Get full text
    Article
  5. 1585

    The Effect of Economic Factors on Coffee Consumption in Rukungiri District, South-Western Uganda by moses Agaba

    Published 2023
    “…Rukungiri District production and marketing department has pursued campaigns to educate the public about the health benefits of coffee, including its high antioxidant content, potential to prevent certain malignancies, and potential to lower type 2 diabetes risk. Despite these efforts, the District still has a low level of coffee consumption. …”
    Get full text
    Article
  6. 1586

    Comparison of Toxic Metal Concentrations in Antidiabetic Herbal Preparations (ADHPs) Available in Bangladesh Using AAS and XRF Analytical Tools by Rausan Zamir, Nazmul Islam, Akhter Faruque

    Published 2019-01-01
    “…Widespread escalation of type 2 diabetes is a concern throughout the world. Developing countries are leading with patients suffering from diabetes-related complications. …”
    Get full text
    Article
  7. 1587

    The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review by R. Floyd, R. Gryson, D. Mockler, J. Gibney, S. N. Duggan, L. A. Behan

    Published 2022-01-01
    “…Polycystic ovarian syndrome (PCOS) is the most common reproductive endocrinopathy in women of reproductive age with many associated metabolic symptoms, in particular hyperinsulinemia, insulin resistance, and a high lifetime risk of type 2 diabetes mellitus. The effects of time-restricted eating on metabolic profiles have been investigated in many endocrinopathies, but there is minimal data for PCOS. …”
    Get full text
    Article
  8. 1588

    The prevalence of chronic kidney disease in people with severe mental illness: A systematic review protocol. by Claire Carswell, Kate Bramham, Joseph Chilcot, Rowena Jacobs, David Osborn, Najma Siddiqi

    Published 2025-01-01
    “…<h4>Background</h4>People with severe mental illness (SMI) are more likely to develop long-term physical health conditions, including type 2 diabetes and cardiovascular disease, compared to people without SMI. …”
    Get full text
    Article
  9. 1589

    The role of insulin signaling with FOXO and FOXK transcription factors by Masaji Sakaguchi

    Published 2024-10-01
    “…In both mice and humans, excessive dietary intake can lead to insulin resistance in various organs, ultimately displaying metabolic syndrome and type 2 diabetes. Insulin signals require thorough regulation to maintain metabolism across diverse environments. …”
    Get full text
    Article
  10. 1590

    Barriers and facilitating factors in the prevention of diabetes type 2 and gestational diabetes in vulnerable groups: A scoping review. by Jessica Breuing, Dawid Pieper, Annika Lena Neuhaus, Simone Heß, Lena Lütkemeier, Fabiola Haas, Mark Spiller, Christine Graf

    Published 2020-01-01
    “…<h4>Aims</h4>Type 2 diabetes mellitus (T2DM) and gestational diabetes (GDM) are globally on the rise, accompanied by comorbidities and associated health costs. …”
    Get full text
    Article
  11. 1591

    Low-grade sarcoma of the cervix: an unusual diagnosis by Maurice José González Basulto, Gustavo de Jesús Crespo Campo, Dayan Cervantes Peláez

    Published 2024-01-01
    “…Patient information: 72-year-old woman, with a history of high blood pressure, type 2 diabetes mellitus and surgery for fibroid, along with necrobiosis, who had to undergo total abdominal hysterectomy with double adnexectomy. …”
    Get full text
    Article
  12. 1592

    Time-Series Analysis of Continuously Monitored Blood Glucose: The Impacts of Geographic and Daily Lifestyle Factors by Sean T. Doherty, Stephen P. Greaves

    Published 2015-01-01
    “…Type 2 diabetes is known to be associated with environmental, behavioral, and lifestyle factors. …”
    Get full text
    Article
  13. 1593

    Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? by Anna R. Carta, Augusta Pisanu, Ezio Carboni

    Published 2011-01-01
    “…Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor (PPAR)-γ agonists commonly used as insulin-sensitizing drugs for the treatment of type 2 diabetes. In the last decade, PPAR-γ agonists have received increasing attention for their neuroprotective properties displayed in a variety of neurodegenerative diseases, including Parkinson's disease (PD), likely related to the anti-infammatory activity of these compounds. …”
    Get full text
    Article
  14. 1594

    Hyperglycaemia after dolutegravir-based antiretroviral treatment in people living with human immunodeficiency virus: A case series by Keerthana Sagadevan, Pilla S. Surya Durga Devi, Katikatala Swaroopa, P. Sathish Sreenivas, R. Srinivasa Rao

    Published 2024-12-01
    “…All such patients were referred to the Medicine Outpatient Department, diagnosed to have type 2 diabetes mellitus and started on appropriate treatment. …”
    Get full text
    Article
  15. 1595

    A New Preprocessing Method for Diabetes and Biomedical Data Classification by Sarbast CHALO, İbrahim Berkan AYDİLEK

    Published 2023-01-01
    “… People of all ages and socioeconomic levels, all over the world, are being diagnosed with type 2 diabetes at rates that are higher than they have ever been. …”
    Get full text
    Article
  16. 1596

    Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus by Nikolaos Vrachnis, Panagiotis Belitsos, Stavros Sifakis, Konstantinos Dafopoulos, Charalambos Siristatidis, Kalliopi I. Pappa, Zoe Iliodromiti

    Published 2012-01-01
    “…Previous Gestational Diabetes Mellitus (pGDM) is a common condition and has been associated with future development of Type 2 Diabetes Mellitus (T2DM) and Metabolic Syndrome (MS) in women affected. …”
    Get full text
    Article
  17. 1597

    In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents by Diana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes, Feliciano Tamay-Cach, Jessica Elena Mendieta-Wejebe

    Published 2021-01-01
    “…Thiazolidinediones (TZDs), used to treat type 2 diabetes mellitus, act as full agonists of the peroxisome proliferator-activated receptor gamma. …”
    Get full text
    Article
  18. 1598

    Charge-Based Inhibitors of Amylin Fibrillization and Toxicity by Sharadrao M. Patil, Andrei T. Alexandrescu

    Published 2015-01-01
    “…To test the hypothesis that electrostatic repulsion is an important force opposing amyloid fibril assembly, we designed peptides that substitute strings of positively or negatively charged residues into the sequence of the amyloidogenic hormone amylin, which contributes to type 2 diabetes pathology. Arg-1 and Arg-2 substitute four positively charged arginines for segments that in structural models of amylin fibrils form the end of strand β1 and the beginning of strand β2, respectively. …”
    Get full text
    Article
  19. 1599

    Genetic, Functional, and Immunological Study of ZnT8 in Diabetes by Qiong Huang, Jie Du, Chengfeng Merriman, Zhicheng Gong

    Published 2019-01-01
    “…A common ZnT8 gene (SLC30A8) polymorphism increases the risk of type 2 diabetes mellitus (T2DM), and rare mutations may present protective effects. …”
    Get full text
    Article
  20. 1600

    Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems by Salwa O. Mekki, Amal A. Hassan, Afnan Falemban, Nashwa Alkotani, Salem M. Alsharif, Ahmed Haron, Basim Felemban, Mohammad S. Iqbal, Aisha Tabassum

    Published 2020-01-01
    “…Here, we present a case of a 52-year-old male who has type 2 diabetes mellitus and a past history of treated pulmonary tuberculosis. …”
    Get full text
    Article